Möchten Sie immer auf dem neuesten Stand bleiben?

TNX-4800 is a long-acting anti-Borrelia burgdorferi OspA human monoclonal antibody in development as a single-dose Lyme prophylactic Phase 1 study of TNX-4800 demonstrated safety, tolerability, and...

Agios announces it will pursue U.S. accelerated approval for mitapivat in sickle cell disease

Acquisition will bring two differentiated commercialized immunology medicines to Biogen with EMPAVELI® FDA-approved in three indications, including two rare kidney diseases, and SYFOVRE® FDA-approved...

Bionic Insights helps HCPs quickly identify key drivers of glucose outcomes, enabling faster decisions and more productive patient discussions.

PRIME designation follows recent Breakthrough Therapy designation from the U.S. FDA, underscoring the importance and urgency of addressing optic neuritis, a serious condition that can have negative...

Enrollment underway in second Avacta clinical program at first three specialist U.S. oncology centers Initial data from the trial expected later this year LONDON and PHILADELPHIA, March 31,...

BASEL, Switzerland, March 31, 2026 (GLOBE NEWSWIRE) -- BioVersys strengthens its Ansamycin Chemistry platform and research on tackling difficult-to-treat non-tuberculous mycobacteria (NTM)...

OTTAWA, March 30, 2026 (GLOBE NEWSWIRE) -- Proponents of public universal health care across Canada are calling for the closure of Grifols facilities in the wake of two deaths in Winnipeg of people...

Dover, DE, March 30, 2026 (GLOBE NEWSWIRE) -- Most people who track their health use more than one app. They have a fitness tracker for steps and sleep, a smartwatch for heart rate, a nutrition app...

Name chosen for AVERSA Fentanyl commercial product